Nyxoah (NYXH) Competitors $2.87 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$2.86 0.00 (-0.17%) As of 05/22/2026 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NYXH vs. BBNX, DCTH, CLPT, CV, and ELMDShould you buy Nyxoah stock or one of its competitors? MarketBeat compares Nyxoah with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nyxoah include Beta Bionics (BBNX), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), CapsoVision (CV), and Electromed (ELMD). These companies are all part of the "medical equipment" industry. NYXH vs. BBNXNYXH vs. DCTHNYXH vs. CLPTNYXH vs. CVNYXH vs. ELMDHow does Nyxoah compare to Beta Bionics?Beta Bionics (NASDAQ:BBNX) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, valuation, institutional ownership, analyst recommendations and media sentiment. Does the media prefer BBNX or NYXH? In the previous week, Beta Bionics had 3 more articles in the media than Nyxoah. MarketBeat recorded 5 mentions for Beta Bionics and 2 mentions for Nyxoah. Nyxoah's average media sentiment score of 0.00 beat Beta Bionics' score of -0.22 indicating that Nyxoah is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk and volatility, BBNX or NYXH? Beta Bionics has a beta of 3.29, meaning that its share price is 229% more volatile than the broader market. Comparatively, Nyxoah has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market. Do analysts recommend BBNX or NYXH? Beta Bionics currently has a consensus price target of $20.00, indicating a potential upside of 69.20%. Nyxoah has a consensus price target of $7.67, indicating a potential upside of 167.13%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beta Bionics 1 Sell rating(s) 3 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.67Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is BBNX or NYXH more profitable? Beta Bionics has a net margin of -60.27% compared to Nyxoah's net margin of -543.21%. Beta Bionics' return on equity of -23.00% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Beta Bionics-60.27% -23.00% -20.55% Nyxoah -543.21%-163.73%-80.24% Which has preferable valuation & earnings, BBNX or NYXH? Beta Bionics has higher revenue and earnings than Nyxoah. Beta Bionics is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeta Bionics$100.25M5.25-$73.20M-$1.51N/ANyxoah$15.33M7.26-$101.92M-$2.48N/A SummaryBeta Bionics beats Nyxoah on 11 of the 15 factors compared between the two stocks.How does Nyxoah compare to Delcath Systems?Delcath Systems (NASDAQ:DCTH) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations. Does the media favor DCTH or NYXH? In the previous week, Delcath Systems had 2 more articles in the media than Nyxoah. MarketBeat recorded 4 mentions for Delcath Systems and 2 mentions for Nyxoah. Delcath Systems' average media sentiment score of 0.27 beat Nyxoah's score of 0.00 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, DCTH or NYXH? Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Nyxoah has a beta of 1.56, meaning that its stock price is 56% more volatile than the broader market. Do institutionals and insiders hold more shares of DCTH or NYXH? 61.1% of Delcath Systems shares are owned by institutional investors. 19.4% of Delcath Systems shares are owned by company insiders. Comparatively, 17.1% of Nyxoah shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts recommend DCTH or NYXH? Delcath Systems presently has a consensus price target of $22.50, suggesting a potential upside of 104.17%. Nyxoah has a consensus price target of $7.67, suggesting a potential upside of 167.13%. Given Nyxoah's higher probable upside, analysts plainly believe Nyxoah is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 2 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.43Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has preferable earnings & valuation, DCTH or NYXH? Delcath Systems has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$85.23M4.46$2.70M$0.011,102.00Nyxoah$15.33M7.26-$101.92M-$2.48N/A Is DCTH or NYXH more profitable? Delcath Systems has a net margin of 0.62% compared to Nyxoah's net margin of -543.21%. Delcath Systems' return on equity of 0.51% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems0.62% 0.51% 0.46% Nyxoah -543.21%-163.73%-80.24% SummaryDelcath Systems beats Nyxoah on 13 of the 16 factors compared between the two stocks.How does Nyxoah compare to ClearPoint Neuro?Nyxoah (NASDAQ:NYXH) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends. Do analysts prefer NYXH or CLPT? Nyxoah presently has a consensus price target of $7.67, suggesting a potential upside of 167.13%. ClearPoint Neuro has a consensus price target of $18.00, suggesting a potential upside of 57.34%. Given Nyxoah's higher probable upside, research analysts plainly believe Nyxoah is more favorable than ClearPoint Neuro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25ClearPoint Neuro 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more volatility and risk, NYXH or CLPT? Nyxoah has a beta of 1.56, suggesting that its stock price is 56% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.29, suggesting that its stock price is 29% more volatile than the broader market. Does the media prefer NYXH or CLPT? In the previous week, ClearPoint Neuro had 2 more articles in the media than Nyxoah. MarketBeat recorded 4 mentions for ClearPoint Neuro and 2 mentions for Nyxoah. ClearPoint Neuro's average media sentiment score of 0.15 beat Nyxoah's score of 0.00 indicating that ClearPoint Neuro is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ClearPoint Neuro 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of NYXH or CLPT? 30.1% of ClearPoint Neuro shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Is NYXH or CLPT more profitable? ClearPoint Neuro has a net margin of -71.57% compared to Nyxoah's net margin of -543.21%. ClearPoint Neuro's return on equity of -140.96% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-543.21% -163.73% -80.24% ClearPoint Neuro -71.57%-140.96%-36.98% Which has preferable earnings & valuation, NYXH or CLPT? ClearPoint Neuro has higher revenue and earnings than Nyxoah. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$15.33M7.26-$101.92M-$2.48N/AClearPoint Neuro$36.97M9.28-$25.54M-$1.01N/A SummaryClearPoint Neuro beats Nyxoah on 11 of the 15 factors compared between the two stocks.How does Nyxoah compare to CapsoVision?CapsoVision (NASDAQ:CV) and Nyxoah (NASDAQ:NYXH) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership. Which has higher valuation & earnings, CV or NYXH? CapsoVision has higher earnings, but lower revenue than Nyxoah. CapsoVision is trading at a lower price-to-earnings ratio than Nyxoah, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCapsoVision$13.55M24.48-$25.32M-$2.34N/ANyxoah$15.33M7.26-$101.92M-$2.48N/A Does the media prefer CV or NYXH? In the previous week, Nyxoah had 1 more articles in the media than CapsoVision. MarketBeat recorded 2 mentions for Nyxoah and 1 mentions for CapsoVision. CapsoVision's average media sentiment score of 0.00 equaled Nyxoah'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CapsoVision 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CV or NYXH more profitable? CapsoVision has a net margin of -198.87% compared to Nyxoah's net margin of -543.21%. CapsoVision's return on equity of 0.00% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets CapsoVision-198.87% N/A -136.03% Nyxoah -543.21%-163.73%-80.24% Do analysts prefer CV or NYXH? CapsoVision presently has a consensus target price of $8.50, indicating a potential upside of 28.01%. Nyxoah has a consensus target price of $7.67, indicating a potential upside of 167.13%. Given Nyxoah's higher possible upside, analysts clearly believe Nyxoah is more favorable than CapsoVision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CapsoVision 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 SummaryCapsoVision beats Nyxoah on 7 of the 13 factors compared between the two stocks.How does Nyxoah compare to Electromed?Nyxoah (NASDAQ:NYXH) and Electromed (NYSE:ELMD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, earnings, institutional ownership, analyst recommendations, valuation and profitability. Which has more risk and volatility, NYXH or ELMD? Nyxoah has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, Electromed has a beta of 0.39, suggesting that its share price is 61% less volatile than the broader market. Does the media prefer NYXH or ELMD? In the previous week, Electromed had 1 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for Electromed and 2 mentions for Nyxoah. Electromed's average media sentiment score of 0.25 beat Nyxoah's score of 0.00 indicating that Electromed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Electromed 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer NYXH or ELMD? Nyxoah presently has a consensus price target of $7.67, suggesting a potential upside of 167.13%. Electromed has a consensus price target of $37.50, suggesting a potential downside of 1.88%. Given Nyxoah's higher probable upside, analysts clearly believe Nyxoah is more favorable than Electromed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Electromed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Do insiders and institutionals hold more shares of NYXH or ELMD? 40.8% of Electromed shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 10.5% of Electromed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is NYXH or ELMD more profitable? Electromed has a net margin of 11.34% compared to Nyxoah's net margin of -543.21%. Electromed's return on equity of 15.71% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Nyxoah-543.21% -163.73% -80.24% Electromed 11.34%15.71%13.37% Which has better earnings and valuation, NYXH or ELMD? Electromed has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNyxoah$15.33M7.26-$101.92M-$2.48N/AElectromed$71.75M4.41$5.15M$1.1732.67 SummaryElectromed beats Nyxoah on 13 of the 17 factors compared between the two stocks. Get Nyxoah News Delivered to You Automatically Sign up to receive the latest news and ratings for NYXH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NYXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NYXH vs. The Competition ExportMetricNyxoahMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$111.24M$1.44B$6.43B$12.32BDividend YieldN/AN/A2.76%5.28%P/E Ratio-1.1664.5621.0125.66Price / Sales7.2622.31615.84111.99Price / CashN/A22.7243.4956.67Price / Book2.667.3810.377.14Net Income-$101.92M-$54.76M$3.57B$335.98M7 Day Performance-1.71%4.80%6.01%3.56%1 Month Performance-3.69%6.69%3.52%2.54%1 Year Performance-62.92%1.47%34.13%35.05% Nyxoah Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NYXHNyxoah1.8961 of 5 stars$2.87flat$7.67+167.1%-62.9%$111.24M$15.33MN/A110Gap DownHigh Trading VolumeBBNXBeta Bionics3.0469 of 5 stars$9.40flat$20.00+112.8%-18.1%$418.86M$100.25MN/A294Positive NewsGap DownDCTHDelcath Systems2.3403 of 5 stars$10.85-2.2%$22.50+107.4%-31.6%$374.54M$85.23M1,085.0060Gap UpCLPTClearPoint Neuro2.2171 of 5 stars$11.17+0.4%$18.00+61.1%-3.8%$334.99M$36.97MN/A110CVCapsoVision1.1611 of 5 stars$6.57+3.3%$8.50+29.4%N/A$328.24M$13.55MN/A90 Related Companies and Tools Related Companies Beta Bionics Competitors Delcath Systems Competitors ClearPoint Neuro Competitors CapsoVision Competitors Electromed Competitors Shoulder Innovations Competitors Carlsmed Competitors Sight Sciences Competitors RxSight Competitors Profound Medical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NYXH) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nyxoah SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Nyxoah With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
